FRIDAY, Dec. 27, 2024 (HealthDay News) A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn’s disease. A new study published recently in the journal Gut shows children with Crohn’s who were prescribed anti-TNF (tumor necrosis factor) drugs following their diagnosis had an 82% lower risk of anal fistulas, or…  read on >  read on >

THURSDAY, Dec. 26, (2024 HealthDay News)  — The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes. Liraglutide, the generic for Victoza, is similar to semaglutide, the active ingredient in the popular weight-loss drug Ozempic. The…  read on >  read on >

The U.S. Food and Drug Administration (FDA) has escalated the recall of certain eggs sold at Costco to its highest Class 1 alert level due to salmonella contamination risks. According to the FDA, The Handsome Brook Farms Kirkland Signature Organic Pasture Raised 24-Count Eggs were distributed to Costco locations in Tennessee, Alabama, Georgia, North Carolina,…  read on >  read on >

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicines that include Ozempic, was cleared to treat moderate to severe OSA in…  read on >  read on >

THURSDAY, Dec. 19, 2024 (HeathDay News) — The U.S. Food and Drug Administration wants to redefine the meaning of healthy food, issuing a new rule Thursday that changes the way food companies can claim their products are indeed nutritious. What foods will qualify for the new designation? Under the final rule, pretty much everything in the…  read on >  read on >

The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA first announced two months ago that any shortage of the medications observed during…  read on >  read on >